https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
391
 
downloads
82
CITE
How to cite this poster:
Hurewitz D, Bernstein J, Bewtra A et al. Absence of inhibitory anti-C1 esterase inhibitor antibody formation in subjects treated with C1 esterase-inhibitor concentrate (Berinert(R)) for successive hereditary angioedema attacks. F1000Posters 2013, 4:45 (poster)

Absence of inhibitory anti-C1 esterase inhibitor antibody formation in subjects treated with C1 esterase-inhibitor concentrate (Berinert®) for successive hereditary angioedema attacks

DS Hurewitz1, JA Bernstein, AK Bewtra, U Kalina, T Machnig, TJ Craig
Published 31 Jan 2013
Author Affiliations
  • Metrics
  • 391 Views
  • 82 Downloads
 
Part of the following:
Browse by related subjects
Published 31 Jan 2013

Absence of inhibitory anti-C1 esterase inhibitor antibody formation in subjects treated with C1 esterase-inhibitor concentrate (Berinert®) for successive hereditary angioedema attacks

[version 1; not peer reviewed]

DS Hurewitz1, JA Bernstein, AK Bewtra, U Kalina, T Machnig, TJ Craig
Author Affiliations
1 Allergy Clinic of Tulsa, Inc., USA
Presented at
American College of Allergy, Asthma & Immunology Annual Scientific Meeting 2012
Abstract
Competing Interests

U Kalina is an employee of CSL Behring.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.